Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
作者:Xingtao Tian、Bingjie Qin、Zhiyuan Wu、Xiaofeng Wang、Hong Lu、Susan L. Morris-Natschke、Chin Ho Chen、Shibo Jiang、Kuo-Hsiung Lee、Lan Xie
DOI:10.1021/jm100738d
日期:2010.12.9
as 13m, 14c, and 14e, displayed high potency with subnanomolar EC50 values, which were more potent than etravirine (TMC125, 1) in the same assays. Notably, these compounds were also highly effective against infection by multi-RTI-resistant strains, suggesting a high potential to further develop these compounds as a novel class of NNRTIs with improved antiviral efficacy and resistance profile.
在我们之前确定的非核苷逆转录酶抑制剂(NNRTIs)的结构和活性的基础上,我们设计并合成了两组衍生物,二芳基吡啶(A)和二芳基苯胺(B),并测试了它们的抗HIV-1活性分别对抗 TZM-bl 和 MT-2 细胞中 HIV-1 NL4-3 和 IIIB 的感染。结果表明,大多数化合物在低纳摩尔 EC 50值下表现出有效的抗 HIV-1 活性,其中一些,如13m、14c和14e显示出高效力,其亚纳摩尔 EC 50值比依曲韦林更有效(TMC125, 1) 在相同的测定中。值得注意的是,这些化合物对多重 RTI 耐药菌株的感染也非常有效,这表明将这些化合物进一步开发为具有改进的抗病毒功效和耐药性的新型 NNRTIs 具有很高的潜力。